Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Researchers are studying Pomaglumetad methionil, tracking side effects to assess long-term safety in people with schizophrenia.
This study ended early.
Multiple locations, including CerritosA Long-Term Study of JNS007ER in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedA Long-term Trial of OPC-34712 in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Kanto RegionResearchers studied Aripiprazole to find out how it affected psychotic symptoms in children with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Chubu RegionA Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
This study ended early.
Multiple locations, including Little Rock
This study has finished and is no longer accepting participants.
Multiple locations, including Washington D.C.This study evaluated the safety of OPC-14597 IMD for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Chugoku RegionA Multicenter Ascending Dose, Double Blind, Placebo-controlled Study of NAP (AL-108) in Chronic Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesThis study evaluated the safety of CVL-231 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleThis study evaluated the safety of aripiprazole IM depot for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosThis study evaluated the safety of ABT-288 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listed
A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended-Release Tablets (SEROQUEL XRâ) in Subjects With Schizophrenia-An Observational, Multicentric Prospective Study
This study has finished and is no longer accepting participants.
Multiple locations, including BusanWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.